Clinical Trials Browser

Interventional × Induction Chemotherapy × Clear all

NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Phase 2 Active not recruiting

293 enrolled 89 charts

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 Recruiting

Nasopharyngeal Carcinoma

NCT07564453 2026-05-04

FLOW

Phase 2 Recruiting

Burkitt Lymphoma

NCT07559045 2026-04-30

Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07472868 2026-03-16

MEND-IT II

Phase 3 Not yet recruiting

Pathologic Complete Response

NCT06484491 2026-01-30

HyDose

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07259473 2026-01-07

Pre-CATALIS

Phase 2 Not yet recruiting

Turcot syndrome

NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Phase 2/3 Active not recruiting

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT06207981 2025-09-02

KANALRAD

Phase 3 Recruiting

Gastrointestinal

Anus Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms, Esophagitis

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

Phase 2 Completed

ESCC

NCT05304468 2025-03-21

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma

NCT05979961 2024-08-06

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Phase 3 Recruiting

Nasopharyngeal Carcinoma

NCT01827553 2024-04-11

CONKO-007

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02031939 2023-08-25

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

NCT01850303 2023-03-14

MODEL

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05628922 2022-11-29

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Phase 2 Recruiting

Nasopharyngeal Neoplasms

NCT05622474 2022-11-18

A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT04143984 2022-04-29

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Phase 3 Unknown

Nasopharyngeal Carcinoma

NCT05232552 2022-02-10

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT05054959 2021-09-23

ICONA

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT01491737 2020-10-28

PERTAIN

Phase 2 Completed

258 enrolled 18 charts

Breast Neoplasms

NCT02627807 2020-06-16

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Phase NA Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT04296747 2020-03-05

Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms

NCT02054819 2019-08-21

Treating NSCLC Minimal Stage IV With Curative Intent

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00167180 2019-07-30

Post Transplant Donor Lymphocyte Infusion

Phase 2 Terminated

57 enrolled 13 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03815903 2019-07-18

INDUCTION

Phase 3 Unknown

Locally Advanced Malignant Neoplasm

NCT00828386 2019-01-18

NPC2006

Phase 3 Terminated

Nasopharyngeal Neoplasms

NCT01872962 2018-04-24

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

Nasopharyngeal Carcinoma

NCT02519712 2018-04-06

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

Phase NA Terminated

4 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03161548 2017-05-30

A Study of Tongue Conservation Surgery for Oral Tongue Cancer

Phase 2 Terminated

Tongue Neoplasms

NCT03011060 2017-01-10

NACVCAC

Phase 3 Unknown

Breast Neoplasm Female

NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Phase 2 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT00002735 2015-09-30

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Phase 2 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00943553 2015-04-13

A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02187315 2014-07-11

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT00460551 2011-12-06

Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer

Phase 2 Terminated

13 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT01247493 2010-11-24

m-FLAI

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00770393 2008-10-10

Laryngeal Preservation in Pyriform Sinus Carcinoma

Phase 2/3 Completed

Carcinoma, Squamous Cell